Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.11 USD | -5.18% | +0.65% | +53.96% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Bullish |
Resistance | 3.850 | 6.090 | 6.090 |
Spread/Res. | -19.22% | -48.93% | -48.93% |
Spread/Supp. | +0.81% | +66.31% | +13.09% |
Support | 3.085 | 1.870 | 2.750 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AQST Stock
- Charts Aquestive Therapeutics, Inc.